Stock listing

Puretech Health Plc

Selected listing: A14VK6 · LS · EUR · DE

Puretech Health Plc (Lang & Schwarz: A14VK6), Health Technology. Latest release Sep 21, 2026: PureTech Announces Successful End-of-Phase 1 Meeting with U.S.…

A14VK6:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A14VK6
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Puretech Health Plc

The company focuses on developing innovative therapies and solutions in the healthcare sector. Its commitment to advancing medical science positions it as a notable player in the industry.

Latest news from Puretech Health Plc

PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS)

September 21, 2026

PRTC's SPTX: New Positive Phase 1 GlyphAllo Data

September 9, 2026

PRTC's Celea:2 Deupirfenidone Presentations at ERS

August 25, 2026

PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial

July 13, 2026

PRTC Launches Celea w/ $180M & Top Tier Syndicate

July 2, 2026

All Puretech Health Plc news →

Events

Replays

PureTech Health plc (PRTC) Q2 2026 Earnings Call
Tue, Sep 22, 2026 · 04:00 AM ET
Watch

Research Puretech Health Plc

Puretech Health Plc company profile

View the public company page for Puretech Health Plc on 6ix.

Puretech Health Plc news

Read company news and market updates connected to Puretech Health Plc.

Puretech Health Plc investor events

Find investor webinars, events, and replay context for Puretech Health Plc.